Zevalin and Cyclophosphamide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Zevalin (ibritumomab tiuxetan) and Cyclophosphamide (cyclophosphamide). Common drug interactions include pneumonia among females and sepsis among males.
The phase IV clinical study analyzes what interactions people have when they take Zevalin and Cyclophosphamide. It is created by eHealthMe based on reports of 467 people who take the same drugs from the FDA, and is updated regularly.
What is Zevalin?
Zevalin has active ingredients of ibritumomab tiuxetan. eHealthMe is studying from 2,258 Zevalin users. Check the latest studies of Zevalin.
What is Cyclophosphamide?
Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
467 people who take Zevalin and Cyclophosphamide together, and have interactions are studied.
What are the common drug interactions of Zevalin and Cyclophosphamide, by gender? *
What are the common drug interactions of Zevalin and Cyclophosphamide, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Zevalin and Cyclophosphamide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Zevalin (2,258 reports)
- Cyclophosphamide (185,240 reports)
Browse all drug interactions of Zevalin and Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zevalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zevalin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cyclophosphamide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on ibritumomab tiuxetan and cyclophosphamide (the active ingredients of Zevalin and Cyclophosphamide, respectively), and Zevalin and Cyclophosphamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cough and Lung Disorder - now
- Remicade and Humira drug interactions for women aged 60+ - 2 seconds ago
- Could Lorazepam cause Skin Disorder? - 3 seconds ago
- Could Janumet cause Gastrointestinal Haemorrhage? - 5 seconds ago
- Could Esomeprazole Magnesium cause Cyst? - 6 seconds ago
- Could Naproxen cause Nephritis - Interstitial? - 6 seconds ago
- Could Naproxen cause Interstitial Nephritis? - 6 seconds ago
- Biotin and Anaemia for Women aged 60+ - 7 seconds ago
- Could Tylenol cause Wheezing? - 9 seconds ago
- Cytarabine and Ezetimibe drug interactions for men aged 60+ - 12 seconds ago